In turn, Young et al. [81] have suggested that the loss of CD154 expression on the myeloma cells leads to the ligand-dependent loss of epithelial growth regulation and uncontrolled inflammations and infections, which may contribute to the increased and uncontrolled susceptibility of patients to the development of cancer. This evidence concerns the gene CD40LG and cancer.